SurgePays, Inc. (SURG) intrinsic value & 10-year financials

SurgePays, Inc. (SURG) has a Graham intrinsic value of $45.84 per share. At $0.12 on Oct 17, 2026, the stock trades 100% below that value. Over the last 10 fiscal years revenue grew 37.2% a year to $57.0M, with an average return on invested capital of -1466.0%.

Graham intrinsic value
$45.84
Share price (Oct 17, 2026)
$0.12
Price vs Graham value
100% below
Market cap
$2.5M
Revenue (FY2025)
$57.0M
Revenue growth (10-yr CAGR)
37.2%
ROIC (10-yr avg)
-1466.0%
Free cash flow (FY2025)
-$21.3M

SURG 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $57.0M -$36.1M -$1.80 -$21.3M -59.9% -1737.1%
FY2024 $60.9M -$45.7M -$2.39 -$21.8M -68.6% -310.7%
FY2023 $137.1M $20.6M $1.38 — 13.8% 150.6%
FY2022 $121.5M -$680.8K -$0.05 $781.9K 0.5% -36.5%
FY2021 $51.1M -$13.5M — -$15.3M -11.7% 217.9%
FY2020 $54.4M -$10.7M — -$4.3M -18.6% 177.1%
FY2019 $25.7M -$8.4M — -$6.8M -30.2% 535.6%
FY2018 $15.2M -$1.5M — -$1.3M -10.1% -27696.0%
FY2017 $1.4M -$2.0M — -$751.1K -144.7% -344.6%
FY2016 $3.3M -$4.6M — -$644.9K -94.2% 14383.2%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

SurgePays, Inc. is a consistent compounder, expanding top-line revenue at 37.2% annually over the past decade.

SurgePays, Inc. has historically struggled to out-earn its cost of capital, averaging just -18.3% ROIC.

Over the decade, SurgePays, Inc. shows that the company has leveraged its balance sheet to sustain operations.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, SurgePays, Inc. is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $45.84 per share.

SURG stock: frequently asked questions

What is the intrinsic value of SurgePays, Inc. (SURG) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 15.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, SURG's intrinsic value is about $45.84 per share.

Is SURG stock undervalued?

At $0.12 (close on Oct 17, 2026), SURG trades 100% below its Graham value of $45.84. On Graham's terms that leaves a margin of safety. A formula is a starting point for research, not a recommendation.

How fast has SurgePays, Inc. grown?

Revenue went from $3.3M in fiscal 2016 to $57.0M in fiscal 2025, a compound annual growth rate of 37.2%. Net income was -$36.1M in fiscal 2025.

Does SurgePays, Inc. generate free cash flow?

SurgePays, Inc. generated -$21.3M of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 1 of the last 9 reported years.

What is SURG's return on invested capital?

Average ROIC over the last 10 fiscal years was -1466.0%, and average return on equity was 22863.4%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this SURG data come from?

From SurgePays, Inc.'s annual 10-K filings on SEC EDGAR, most recently filed May 20, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar telephone communications stocks